Cite
Transition to ePrescribing for systemic anti-cancer therapy – Perceptions of a multidisciplinary haematology/oncology team in a large teaching hospital.
MLA
O’Connor, Hannah, et al. “Transition to EPrescribing for Systemic Anti-Cancer Therapy – Perceptions of a Multidisciplinary Haematology/Oncology Team in a Large Teaching Hospital.” Journal of Oncology Pharmacy Practice, vol. 29, no. 6, Sept. 2023, pp. 1404–17. EBSCOhost, https://doi.org/10.1177/10781552221126102.
APA
O’Connor, H., Melanophy, G., Martin, C. M., Flattery, M., & O’Dea, E. (2023). Transition to ePrescribing for systemic anti-cancer therapy – Perceptions of a multidisciplinary haematology/oncology team in a large teaching hospital. Journal of Oncology Pharmacy Practice, 29(6), 1404–1417. https://doi.org/10.1177/10781552221126102
Chicago
O’Connor, Hannah, Gail Melanophy, Carlos Medina Martin, Martin Flattery, and Edel O’Dea. 2023. “Transition to EPrescribing for Systemic Anti-Cancer Therapy – Perceptions of a Multidisciplinary Haematology/Oncology Team in a Large Teaching Hospital.” Journal of Oncology Pharmacy Practice 29 (6): 1404–17. doi:10.1177/10781552221126102.